MarketInOut Stock Screener Log In | Sign Up
 

VolitionRX Ltd

NYSE • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
VolitionRX Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNYSE
Market Capitalization5.23 mln
Float25.19 mln
Earnings Date11/12/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-6.19
Highly reliable

1-Year Forecast

13.62
Transformational upside

Relative Strength

4 / 100
Severely lagging

Pre-Tax Margin

-1,047%
Severely loss-making

ROE

77.10
Exceptional

Business Description

VolitionRx Limited is a Nevada-based company operating across the United States, Europe, and Asia that develops blood tests to identify and track cancer and other serious illnesses. Its products cover a wide range of needs, from screening animals for cancer to helping doctors monitor how well a patient is responding to treatment. The company also offers tools for studying genetic material in the blood, including methods to isolate cancer-related DNA at an early stage. VolitionRx serves both human and veterinary medicine, making it a broad player in the field of disease detection through blood analysis.

Key Fundamentals

EPS-3.80
ROE77.10
RPS0.36
ROIC-199
ROA-325
Interest Cover-5.93
EBITDA, mln-20.91
EV / EBITDA-0.50
EV / EBIT-0.48
Revenue, mln2.46
EV / Revenue4.29

Quote Details

Last 0.1741
Change 0.005 (2.96%)
Open 0.1652
Volume 506,394
Turnover 88,163
Average Volume 1,468,218

Financial Ratios

Pre-Tax Profit Margin-1,047
Current Ratio0.30
Price / Sales0.68

Financial Strength

Altman Z-Score-54.82
Piotroski F-Score 4 / 9
Beneish M-Score-6.19
1-Year Target Price13.62
Short Ratio0.37
Short % of Float4.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.33% 13 / 100   
1 Month -29.17% 3 / 100   
2 Months -84.59% 0 / 100   
6 Months -93.78% 0 / 100   
1 Year -97.94% 0 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog